SeaView Research

SeaView Research is a company focused on providing expert market analysis and strategic insights for the pharmaceutical and biotechnology sectors, helping clients navigate complex industry challenges. Founded in 1995 by James Pidgeon in Miami, US, SeaView Research specializes in market analysis for the pharmaceutical and biotechnology industries. The company has undergone a significant change, having been acquired by Quotient Clinical, a portfolio company of GHO Capital, in February 2017. The firm has completed a total of 1 deal since its inception.

SeaView Research offers comprehensive market analysis and strategic consulting services tailored for the pharmaceutical and biotechnology sectors. Their expertise aids clients in making informed business decisions by providing detailed insights into market dynamics, competitive landscapes, and growth opportunities. The company serves a diverse clientele, including established pharmaceutical firms and emerging biotech companies, across various therapeutic areas. SeaView Research generates revenue through consulting contracts with pharmaceutical and biotechnology companies, engaging clients in partnerships that typically cover comprehensive market analysis services.

The pricing structure is likely based on the complexity of the services provided, potentially including fixed fees and performance-based incentives contingent upon the delivery of specific reports and strategic insights. In the wake of its acquisition by Quotient Clinical in February 2017, SeaView Research aims to enhance its service offerings by developing new analytical tools and methodologies to better serve the evolving needs of its clients. The company plans to expand its operations into new geographic regions, targeting markets in Europe and Asia by 2025. The recent acquisition has enabled SeaView Research to leverage additional resources for these growth initiatives, focusing on increasing their market presence and enhancing client engagement through innovative solutions.